Understanding the impact of chronic red blood cell transfusion on day-to-day functioning in sickle cell disease (SCD): A mixed methods study of pediatric and adult experience

C Chinonso Onuoha (1University of North Carolina, Department of Pediatric Hematology/Oncology, Chapel Hill, United States) P Paul Mihas (2University of North Carolina, Odum Institute for Research in social science, Chapel Hill, United States) M Marcella Boynton (3University of North Carolina, Division of General Medicine and Clinical Epidemiology, Chapel Hill, United States) S Stephanie Sperry (4University of North Carolina, Gillings School of Global Public Health, Chapel Hill, United States) A Ada Chang (3University of North Carolina Chapel Hill, Chapel Hill, United States) L Lindsey Akpuogu (5University of North Carolina, Division of Hematology, Chapel Hill, United States) D David Wichlan (5University of North Carolina, Division of Hematology, Chapel Hill, United States) I Izabela Pawlinski (6University of North Carolina, UNC Blood Research Center, Chapel Hill, United States) S Samuel Wilson J Jane Little M Matthew Karafin (1University of North Carolina at Chapel Hill, Pathology and Laboratory Medicine, Chapel Hill, United States) J Jacquelyn Baskin-Miller (1University of North Carolina, Department of Pediatric Hematology/Oncology, Chapel Hill, United States)

Abstract

Abstract Background Chronic red blood cell transfusion (CRCT) is a therapeutic cornerstone for individuals with sickle cell disease (SCD), commonly used for stroke prevention, preoperative optimization, during pregnancy, and management of severe cardiopulmonary disease. While patients often report improved health-related quality of life (HRQoL), the day-to-day impact of transfusion is poorly understood. Therefore, our study aimed to comprehensively assess the symptom and procedural burden of chronic CRCT in individuals with SCD by capturing both quantified impacts and lived experiences via interviews across pediatric and adult populations. Methods We conducted a single-center mixed-methods study in non-gravid pediatric and adult patients with a diagnosis of SCD, who had been receiving CRCT, either manual or automated, for ≥6 months. Quantitative data collection included the ASCQ-Me Short Forms v2.0 for adults and the PedsQL v4.0 for pediatric participants. Adult survey data were analyzed descriptively using mean scores and standard deviations for each domain, while pediatric responses were summarized using score ranges due to the small sample size. Categorical variables such as age, gender, race, and transfusion indications were reported as frequencies and percentages. Per scoring conventions, ASCQ-Me scores were converted to standardized T-scores (mean = 50, SD = 10), and PedsQL scores were reverse-scored and linearly transformed to a 0–100 scale, with higher scores indicating better functioning for both instruments. Qualitative data were collected through age-appropriate, semi-structured interview guides with tailored probes. A single trained study team member conducted all interviews in a private setting to ensure consistency. Interviews were audio-recorded, transcribed verbatim, and thematically analyzed using inductive line-by-line coding in MAXQDA software. Results Of the 37 participants who consented, 20 had surveys completed on the day of transfusion that were available for analysis (adults n=17; pediatric patient/caregiver dyads n=3), and 13 participants (9 adults, 4 pediatric patients) completed qualitative interviews. Among adults, 53% were female, 88% identified as Black/African American, and 82% had hemoglobin SS genotype; Stroke (35%) and pain (29%) were the most common indications for CRCT. Adults reported the greatest burden in pain (M=34.7, SD=31.7) and stiffness(M=25.0, SD=24.9), with consistently lower-than-average scores (M < 50) across emotional, sleep, and social domains when compared to the SCD field test reference population. In the three children (ages 8–13 years), all had hemoglobin SS genotype and received CRCT for stroke prevention. Children reported better functioning across physical, emotional, social, and school domains compared to caregiver proxy reports. However, caregivers reported lower functioninginphysical activity (range: 20–80 vs. 60–95) and school (range: 25–83 vs. 33–92) compared to their child's reports. Four overarching qualitative themes emerged in both adults and children: (1)“Fatigue is my normal” – Participants described a cyclical pattern of fatigue, with transient improvement after transfusion and a predictable energy decline 2–3 weeks later. (2) “Every access comes with a price” – Repeated IV sticks, port complications, and scarring contributed to fear, pain, and stigma. (3) “Getting there is half the battle” – Transportation barriers and post-transfusion fatigue frequently disrupted care. (4) “Caught between transfusion and classroom/work” – Treatment schedules interfered with school and job responsibilities, leading to frequent absenteeism. Conclusion This is the first study to integrate quantitative and qualitative data to comprehensively characterize the multidimensional burden of CRCT among pediatric and adult patients with SCD. Adult survey results revealed significant impairments in sleep, physical and psychosocial functioning, particularly in pain and stiffness; while interviews highlighted modifiable challenges, such as vascular access, transportation, and life balance, vs possibly disease-associated fatigue. These findings underscore the need for patient-centered interventions that minimize procedural burden, address transportation concerns, and promote school and work participation. Ongoing cross-sectional and longitudinal data will further enhance understanding of patient burden, and these early insights may provide a foundation for future research and care redesign.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue Supplement 1
Published November 03, 2025
Pages 2949-2949
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (12)

C

Chinonso Onuoha

1University of North Carolina, Department of Pediatric Hematology/Oncology, Chapel Hill, United States

P

Paul Mihas

2University of North Carolina, Odum Institute for Research in social science, Chapel Hill, United States

M

Marcella Boynton

3University of North Carolina, Division of General Medicine and Clinical Epidemiology, Chapel Hill, United States

S

Stephanie Sperry

4University of North Carolina, Gillings School of Global Public Health, Chapel Hill, United States

A

Ada Chang

3University of North Carolina Chapel Hill, Chapel Hill, United States

L

Lindsey Akpuogu

5University of North Carolina, Division of Hematology, Chapel Hill, United States

D

David Wichlan

5University of North Carolina, Division of Hematology, Chapel Hill, United States

I

Izabela Pawlinski

6University of North Carolina, UNC Blood Research Center, Chapel Hill, United States

S

Samuel Wilson

J

Jane Little

M

Matthew Karafin

1University of North Carolina at Chapel Hill, Pathology and Laboratory Medicine, Chapel Hill, United States

J

Jacquelyn Baskin-Miller

1University of North Carolina, Department of Pediatric Hematology/Oncology, Chapel Hill, United States